BurstDR stimulation is preferred to traditional "tingling" tonic stimulation by 87% of patients.9 Clinically proven therapy: The Eterna SCS system features Abbott's proprietary BurstDR stimulation, which mimics natural firing patterns found in the brain7 to deliver superior**8 pain relief. Smallest device: Designed with daily comfort in mind6 the Eterna SCS system is the smallest implantable, rechargeable spinal cord stimulator*4 on the market. With patient needs front of mind, Abbott created Eterna to be recharged less than five times a year under normal use, making it the lowest recharge burden platform on the market.§1,2,3 The studies found that people wanted a smaller implant for comfort while reducing the need to charge the device daily or weekly. Food and Drug Administration (FDA) approval of the company's Eterna(TM) spinal cord stimulation (SCS) system - the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment of chronic pain.*4 Eterna SCS utilizes Abbott's proprietary low-dose BurstDR(TM) stimulation, the only SCS waveform technology with the highest level of clinical evidence (1A evidence), proven to reduce pain 23% more than traditional waveform technology approaches.5Ībbott developed Eterna based on extensive studies with patients, physicians and caregivers to understand the unmet needs of people living with chronic pain. Abbott (NYSE: ABT) today announced the U.S. This neuromodulation device provides an optimized experience with the ability to wirelessly charge as few as five times per year, the lowest recharge burden compared to other rechargeable SCS systems §1,2,3ĪBBOTT PARK, Ill. Food and Drug Administration (FDA) approved Abbott's Eterna(TM) spinal cord stimulation (SCS) system for the treatment of chronic pain
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |